Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2014, Pages

  Gordon, Morris ^a,b   Taylor, Kelly ^c   Akobeng, Anthony K ^d   Thomas, Adrian G ^d  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PLACEBO; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ABSCESS; ALOPECIA; ANEMIA; ANGINA PECTORIS; ARTHRALGIA; BRONCHITIS; CROHN DISEASE; DERMATITIS; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FLATULENCE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; HYPERTRANSAMINASEMIA; HYPOTENSION; INCIDENCE; INFLUENZA; INTENTION TO TREAT ANALYSIS; INTERSTITIAL NEPHRITIS; JAUNDICE; LEUKOPENIA; MAINTENANCE THERAPY; MALAISE; MALIGNANT NEOPLASM; METALLIC TASTE; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; PHLEBITIS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; RHINOPHARYNGITIS; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT DURATION; VOMITING; MAINTENANCE CHEMOTHERAPY; META ANALYSIS; METHODOLOGY;

6-MERCAPTOPURINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; AZATHIOPRINE; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAINTENANCE CHEMOTHERAPY; MESALAMINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REMISSION INDUCTION;

EID: 84907222744     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010233.pub2     Document Type: Review

References (43)

1. Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127(3):730-40.
2. Armuzzi A, Felice C, Marzo M, Pugliese D, Andrisani G, Papa A, et al. Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: A pilot study. Digestive and Liver Disease 2012;44:S194.
3. Armuzzi A, Felice C, Marzo M, Pugliese D, Andrisani G, Papa A, et al. Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: An open-label pilot study. Gastroenterology 2012;142(5 Suppl 1):S780.
4. Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, et al. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. Journal of Crohn's and Colitis 2013;7(12):e623-9.
5. D'Haens G, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroeneterology 2008;135(4):1123-9.
6. D'Haens GR, Noman M, Van Assche GA, Van Olmen G, Aerden I, Vermeire S, et al. Combination therapy with metronidazole and azathioprine reduces severe postoperative recurrence of Crohn's disease: A double-blind controlled randomized trial. Gastroenterology 2007;132(4 Suppl 1):A52.
7. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine or placebo: a 2-year trial. Gastroenterology 2004;127(3):723-9.
8. Korelitz B, Hanauer S, Rutgeerts P, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trial. Gastroenterology 1998;114(4 Part 2):A486.
9. Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Muller R, et al. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Therapeutic Drug Monitoring 2007;29(1):1-5.
10. Herfarth H, Obermeier F, Tjaden C, Lukas M, Serclova Z, Dignass AU, et al. Double-blind, double dummy, randomized, multicentre, comparative study on the efficacy and safety of azathioprine (AZA) versus mesalazine (5-ASA) for prevention of postoperative endoscopic recurrence in Crohn's disease. Gastroenterology 2006;130(4 Suppl 2):A480-1.
11. Herfarth H, Tjaden C, Lukas M, Obermeier F, Dilger K, Muller R, et al. Adverse events in clinical trials with azathioprine and mesalamine for the prevention of postoperative recurrence of Crohn's disease. Gut 2006;55(10):1525-6.
12. Angelberger S, Schaeffeler E, Teml A, Petritsch W, Shonova O, Lukas M, et al. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels. Inflammatory Bowel Diseases 2013;19(3):590-8.
13. Angelberger S, Schaeffeler E, Teml A, Petritsch W, Shonova O, Lukas M, et al. Relationship between thiopurine metabolite levels and endoscopic improvement in patients with postoperative moderate to severe endoscopic recurrence of Crohn's disease. Gastroenterology 2010;138(5 Suppl 1):S685.
14. Reinisch W, Angelberger S, Petritsch W, Herrlinger K, Shonova O, Lukas M, et al. A double-blind, double-dummy, randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs mesalamine for prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrence. Gastroenterology 2008;134(4 Suppl 1):A70.
15. Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, et al. Azathioprine versus mesalazine for the prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomized, double-blind, double-dummy, multicentre trial. Gut 2010;59(6):752-9.
16. Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Greinwald R, et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: Follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial. Journal of Crohn's and Colitis 2013;7:S254.
17. Reinisch W, Stange EF. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease - the authors' response. Gut 2011;60(5):739-40.
18. Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease - a randomized trial. Digestive and Liver Disease 2013;45:S94-5.
19. Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. American Journal of Gastroenterology 2013;108(11):1731-42.
20. Savarino E, Bodini G, Dulbecco P, Marabotto E, Assandri L, Bruzzone L. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease - a randomized trial. Gastroenterology 2013;144(5 Suppl 1):S21.
21. Ferrante M, Papamichael K, Duricova D, D'Haens G, Vermeire S, Archavlis E, et al. Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn's disease recurrence. Journal of Crohn's and Colitis 2014;8:S205-6.
22. Manosa M, Cabre E, Bernal I, Esteve M, Garcia- Planella E, Ricart Gomez E. Azathioprine versus azathioprine plus metronidazole for the prevention of postoperative endoscopic recurrence of Crohn's disease: A randomized, placebo-controlled trial. Journal of Crohn's and Colitis 2012;6:S93.
23. Mañosa M, Cabré E, Bernal I, Esteve M, Garcia-Planella E, Ricart E, et al. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial. Inflammatory Bowel Diseases 2013;19(9):1889-95.
24. Nos P, Hinojosa J, Aguilera V, Moles JR, Pastor M, Ponce J, et al. Azathiprine and 5-ASA in the prevention of postoperative recurrence in Crohn's disease. Gastroenterología y Hepatología 2000;23(8):374-8.
25. Benchimol EI, Seow CH, Otley AR, Steinhart AH. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD002913.pub2]
26. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Annals of Surgery 2000;231(1):38-45.
27. Colonna T, Korelitz BI. The role of leukopenia in the 6-mercaptopurine induced remission of refractory Crohn's disease. American Journal of Gastroenterology 1994;89(3):362-6.
28. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD006873.pub2]
29. Gordon M, Naidoo K, Thomas AG, Akobeng AK. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD008414.pub2]
30. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
31. Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, et al. Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate [Le mycophénolate mofétil dans les formes chroniques actives de la maladie de Crohn après échec de lazathioprine ou du méthotrexate]. Gastroenterologie Clinique et Biologique 2002;26(1):17-22.
32. Hanauer SB, Sandborn W. Management of Crohn's disease in adults. American Journal of Gastroenterology 2001;96(3):635-43.
33. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
34. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
35. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of published research articles. JAMA 1999;281(12):1110-1.
36. Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000067.pub2]
37. Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pasci M, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009;136(2):441-50.
38. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
39. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall FJ. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD004826.pub2]
40. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99(4):956-63.
41. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
42. Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD000301]
43. Williams JG, Wong WD, Rothenberger DA, Goldberg SM. Recurrence of Crohn's disease after resection. British Journal of Surgery 1990;78(1):10-9.